Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 820 participants.
Also called NCT07389460
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 820 participants
- Sponsor
- Registry
-
NCT07389460
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07389460. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-07 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Intravenous rhPro-UK
- Intervention (Drug)
- Intravenous placebo
- Intervention (Procedure)
- Endovascular thrombectomy
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Collaborator
- Tasly Pharmaceutical Group Co., Ltd
- Collaborator
- Peking Union Medical College Hospital
Record details
- Record id
cardio:ct-nct07389460- Content hash
bb3c9cfbb838942bfba58eafe9716a81a0d748ec16b1dd1c7b69b65d008d126f